{"title": "Seminario Reflujo Gastroesofagico", "author": "Internista en Bucaramanga", "url": "https://www.slideshare.net/sandraacevedomd/seminario-reflujo-gastroesofagico", "hostname": "slideshare.net", "description": "Seminario Reflujo Gastroesofagico - Descargar como PDF o ver en l\u00ednea de forma gratuita", "sitename": "SlideShare", "date": "2012-11-27", "cleaned_text": "7. 1. Longitud total de engrosamiento muscular esof\u00e1gico distal. 2. Longitud de es\u00f3fago intraabdominal 4. Presi\u00f3n t\u00f3nica o presi\u00f3n de reposo del esf\u00ednter esof\u00e1gico inferior 3. El \u00e1ngulo de His Gastroenterol Clin North Am 2007 36:577 Zona de Alta Presi\u00f3nZona de Alta Presi\u00f3n 8. Histolog\u00edaHistolog\u00eda Epitelio plano estratificado. Mucosa (tejido linf\u00e1tico difuso, gl\u00e1ndulas mucosas). Submucosa (vasos, nervios, plexo de Meissner, gl\u00e1ndulas). Muscular (interna, externa). 1/3 superior estriado, 2/3 inferiores liso. Plexo de Auerbach. 9. Estructura de la pared esof\u00e1gica en la uni\u00f3n esofagog\u00e1strica. La t\u00fanica muscular est\u00e1 formada por una capa longitudinal y una capa circular. (a = muscular de la mucosa, b = l\u00e1mina propia, c = epitelio, G1 = gl\u00e1ndulas esof\u00e1gicas, G2 submucoso.) 13. Episodios de reflujo normal...Episodios de reflujo normal... Frecuentes durante y despu\u00e9s de las comidas Duraci\u00f3n <5 minutos Excepcionalmente >10 minutos Sin complicaciones Raros en las noches 14. Definici\u00f3n ERGE es una afecci\u00f3n recurrente, relacionada con el reflujo retr\u00f3grado del contenido g\u00e1strico, con o sin contenido duodenal, hacia el es\u00f3fago. Presenta un variado espectro de s\u00edntomas que pueden alterar la calidad de vida del paciente y puede presentarse con o sin da\u00f1o tisular. (votaci\u00f3n: 100% aceptaci\u00f3n) Cohen et al. EUJ Gastroenterol Hepatol 2006 EnfermedadporReflujoEnfermedadporReflujo Gastroesof\u00e1gicoGastroesof\u00e1gico 15. Definici\u00f3n Montreal Working GroupMontreal Working Group Acidez es considerada molesta si s\u00edntomas leves ocurren dos o m\u00e1s d\u00edas a la semana \u00f3 si hay s\u00edntomas moderados a severos m\u00e1s de un d\u00eda a la semana Cohen et al. EUJ Gastroenterol Hepatol 2006 16. Pirosis Sensaci\u00f3n de quemaz\u00f3n retroesternal ascendente y para el diagn\u00f3stico de ERGE, debe estar presente 2 o m\u00e1s veces por semana, durante m\u00e1s de 3 meses en el \u00faltimo a\u00f1o, no necesariamente continuo. (votaci\u00f3n: 71,4%) Regurgitaci\u00f3n Retorno sin esfuerzo del contenido g\u00e1strico al es\u00f3fago y algunas veces a la boca. (votaci\u00f3n: 100%) Cohen et al. Asociaciones propuestas 1) Sindrome de reflujo t\u00edpico 2) Sindrome de dolor tor\u00e1cico por reflujo 1) Esofagitis por reflujo 2) Estenosis por reflujo 3) Es\u00f3fago de Barrett 4) AdenoCa esof\u00e1gico 1) Sd. tos por reflujo 2) Sd. laringitis por reflujo 3) Sd. asma por reflujo 4) Sd. erosi\u00f3n dental por reflujo 1) Faringitis 2) Sinusitis 3) Fibrosis pulmonar idiop\u00e1tica 4) Otitis media recurrente 20. Grado de esofagitis % Pacientes con pirosis moderada o severa 0 20 40 60 80 100 1 2 3 4 Carlsson et al 1996 Severidad de los s\u00edntomas y grado deSeveridad de los s\u00edntomas y grado de esofagitis no se correlacionanesofagitis no se correlacionan (meta-an\u00e1lisis, n=3478)(meta-an\u00e1lisis, n=3478) 35. 14% de la poblaci\u00f3n mayor de 65 a\u00f1os los toma regularmente. No requieren receta m\u00e9dica. Tienen alto perfil de seguridad, sin toxicidad aguda, y con pocos efectos adversos reportados, entre ellos: Neumon\u00eda adquirida en la comunidad Osteoporosis Hiperplasia de c\u00e9lulas G Deficiencia en absorci\u00f3n de B12 y hierro P\u00f3lipos f\u00fandicos Efecto de \"rebote\" dose in a BID regimen has not been shown to be superior in the treatment of GERD. 38. Y los casos refractarios?Y los casos refractarios? S\u00edntomas o evidencia de esofagitis - IBP dos veces al d\u00eda 10-40% no responden Sin esofagitis erosiva: Rta 40% Con esofagitis erosiva: Rta 56% Cuando se encuentra en reposo el es\u00f3fago est\u00e1 colapsado ; forma un conducto muscular blando, aplanado en sus porciones superior y media, con un di\u00e1metro de 2,5 \u00d7 1,6 cm. La porci\u00f3n inferior del es\u00f3fago es redondeda, con un di\u00e1metro de 2,5 \u00d7 2,4 cm.51 De vez en cuando existe una marca ocasionada por el diafragma, pero son m\u00e1s evidentes dos constricciones musculares funcionales: los esf\u00ednteres esof\u00e1gicos superior e inferior. Estos pueden definirse mediante manometr\u00eda, respectivamente, en el comienzo del es\u00f3fago, a una distancia de 14 a 16 cm desde los incisivos , y en la desembocadura del es\u00f3fago en el est\u00f3mago, a una distancia de 40 a 45 cm desde los incisivos En el adulto var\u00eda entre 22 y 28 cm (24 \u00b1 5 desviaciones est\u00e1ndar), de los cuales 3 a 6 cm se localizan en el abdomen.17,32,67 A diferencia de Lerche,32 Liebermann-Meffert y cols.35 encontraron que la longitud del es\u00f3fago se relaciona con la estatura de la persona m\u00e1s que con su sexo Como estructura que sigue a la faringe (v\u00e9ase fig. 1-4), el es\u00f3fago comienza en el cart\u00edlago cricoides a la altura de la sexta v\u00e9rtebra cervical . Penetra en el t\u00f3rax a la altura de la muesca esternal y en la cavidad tor\u00e1- cica se ubica en el l\u00edmite anterior del mediastino posterior. Entre la abertura tor\u00e1cica superior y el diafragma se mantiene en contacto con la columna vertebral. Termina en la uni\u00f3n esofagog\u00e1strica, a la altura de la duod\u00e9cima v\u00e9rtebra tor\u00e1cica. En el cuello, las arterias tiroideas superior e inferior emiten ramas descendentes peque\u00f1as para el es\u00f3fago cervical. En la concavidad del cayado a\u00f3rtico surgen tres a cinco arterias traqueobronquiales que originan varias ramas esof\u00e1gicas. De vez en cuando, de la pared anterior de la aorta tor\u00e1cica surgen una o dos arterias esof\u00e1gicas. En la uni\u00f3n esofagog\u00e1strica la arteria g\u00e1strica izquierda (coronaria estom\u00e1quica) origina hasta 11 ramas ascendentes de gran tama\u00f1o que irrigan principalmente las caras anterior y derecha de la porci\u00f3n inferior del es\u00f3fago35,37 (v\u00e9ase fig. 1-17). Los vasos originados en la arteria espl\u00e9nica irrigan la pared esof\u00e1gica posterior y parte de la curvatura mayor del est\u00f3mago . Algunas ramas de gran tama\u00f1o se dirigen hacia arriba a trav\u00e9s del hiato diafragm\u00e1tico y luego penetran en la pared esof\u00e1gica Este autor clasific\u00f3 las venas esof\u00e1gicas en intr\u00ednsecas y extr\u00ednsecas, seg\u00fan se encontraran dentro o fuera de la pared esof\u00e1gica. Las venas intraesof\u00e1gicas incluyen el plexo subepitelial en la l\u00e1- mina propia de la mucosa cerca del epitelio. Este plexo recibe sangre de los capilares adyacentes y drena hacia el plexo submucoso, que incluye vasos que se unen y forman venas comunicantes peque\u00f1as. \u00c9stas se disponen principalmente a lo largo del eje longitudinal.64 Aharinejad y cols.1 estudiaron la microvasculatura del es\u00f3fago humano minuciosamente. Describieron dos peque\u00f1as venas que por lo general acompa\u00f1an las arterias circunferenciales de la l\u00e1mina submucosa como venas perforantes originadas a partir de las peque\u00f1as venas comunicantes del plexo submucoso y atraviesan la pared muscular del es\u00f3fago junto con las arterias perforantes. \u00c9stas reciben venas tributarias provenientes de la capa muscular y forman entonces las venas extr\u00ednsecas extramurales en la superficie del es\u00f3fago.1,7,64 En el sistema circulatorio venoso del es\u00f3- fago no se encontraron v\u00e1lvulas.1,7,64 Las venas extr\u00ednsecas drenan hacia los vasos locales de mayor tama\u00f1o correspondientes; \u00e9stos son las venas tiroideas superior e inferior, que desembocan en las venas braquiocef\u00e1lica y yugular, las venas \u00e1cigos y hemi\u00e1cigos (o \u00e1cigos menor) y las venas g\u00e1strica y espl\u00e9nica No obstante, puede aceptarse que el sistema linf\u00e1tico del es\u00f3fago incluye conductos y ganglios linf\u00e1ticos, como los descritos en otras partes del intestino. ___ La inervaci\u00f3n del es\u00f3fago depende del componente visceral (espl\u00e1cnico) del sistema nervioso aut\u00f3nomo . \u00c9ste incluye el sistema simp\u00e1tico y el sistema parasimp\u00e1tico, que ejercen influencias antag\u00f3nicas sobre el es\u00f3fago. Las distintas v\u00edas nerviosas se han descrito en detalle.8,20,66 Los troncos nerviosos y sus ramas principales est\u00e1n formados por haces nerviosos paralelos que contienen axones eferentes o aferentes. El tronco nervioso est\u00e1 rodeado por el epineuro, una vaina de tejido conectivo denso. El es\u00f3fago normal est\u00e1 recubierto de epitelio escamoso estratificado, el cual se extiende hasta la uni\u00f3n gastroesof\u00e1gica, que es una l\u00ednea imaginaria donde hace contacto con el epitelio columnar g\u00e1strico en la interfaz que se denomina l\u00ednea Z. O sea, que la l\u00ednea Z es la uni\u00f3n escamo-columnar. La mucosa esof\u00e1gica corresponde a un epitelio escamoso estratificado (no queratinizado) que recubre la l\u00e1mina propia con numerosas papilas de tejido conjuntivo. (15-10) Stevens la mucosa (mismo tipo) pero con lamina propia y muscular de la mucosa. La zona basal del epitelio puede tener varias capas de c\u00e9lulas de grosor y consiste en c\u00e9lulas cubicas rectangulares con nucleos oscuros y un citoplasma que se ti\u00f1e de morado y no tiene gluc\u00f3geno. Encima de la zona basal las c\u00e9lulas epiteliales son de mayor tama\u00f1o y ricas en gluc\u00f3geno y se van aplanando conforme se acercan a la luz. La lamina propia esof\u00e1gica esta compuesta por fibras de col\u00e1geno poco ordenadas y fibrtoblastos incluidos en una matriz acelular de glucosaminoglucanos, normalmente con linfocitos y eosinofilos diseminados. La muscular de la mucosa no existe en la parte superior del es\u00f3fago, pero se organiza cerca del est\u00f3mago. Tanto la mucosa como la submucosa del es\u00f3fago no distendido crean pliegues longitudinales que dan a la luz un contorno irregular. Cuando el bolo alimentario desciende por el es\u00f3fago, los pliegues desaparecen de forma transitoria y posteriormente reaparecen por la retracci\u00f3n de las fibras el\u00e1sticas de la have endoscopic or histopathologic evidence of esophageal inflammation. Due to the broad spectrum of conditions attributable to reflux, there is little troublesome if mild symptoms occur two or moderate to severe symptoms occur more than one day a week There are limitations in the epidemiologic estimates of the prevalence of gastroesophageal disease that heartburn and/or Barrett's esophagus) do not always have heartburn and heartburn is not always indicative of GERD [6]. A systematic was found to be 10 to 20 percent in the Western world and less than 5 percent in Asia. The incidence in the Western world was approximately 5 per 1000 person-years. In a subsequent population-based survey in the United States, 22 percent of respondents reported that they had heartburn or The in retrosternal area [2], most commonly experienced in the postprandial period. Regurgitation is defined as the perception of flow common back, neck, jaw, or anywhere from minutes to hours, resolving either antacids. It usually occurs pain have evidence by brash or hypersalivation can foam at the mouth, secreting as much as 10 mL of saliva per minute in response to reflux. Globus sensation is the the throat (irrespective of swallowing), which has been related to some studies. However, the role of esophageal reflux in this disorder is uncertain. One study suggested that globus was associated indicates an esophageal ulcer. Nausea is infrequently reported considered in adults\". Histology \u2014 A review of the literature suggested that about two-thirds of patients who have symptoms of GERD, but have visible endoscopic findings seen on transmission electron the basal cell layer and elongation of the papillae of the epithelium (picture 1) [13]. diagnosis described to antisecretory therapy is not a diagnostic [15]. meta-analysis of diagnostic that (PPIs) not a response diagnosis based on reflux testing. However, the observation percent of patients symptoms in practice. Clearly, it necessary nor practical to confirm the diagnosis of and to rule out other diagnoses (see 'Overview' below). Upper The indications for upper endoscopy in patients with GERD are controversial and are discussed detail (See \"Medical of metaplasia, dysplasia, or, in the absence of visual abnormalities, schemes, two most dominant will be described Los Angeles classification \u2014 The Los Angeles classification is the most thoroughly evaluated classification for break refers to an area of slough adjacent to more normal mucosa in the squamous or without includes all complications, grade IV esophagitis grade IV With so many proposed modifications, grades IV and V no longer meaning. The findings or linear, multiple, infectious ulcers are multiple and punctate. Pill-induced ulcerations are singular and deep, occurring at points of stasis (especially near the carina), with of the distal esophagus. (See \"Medication-induced esophagitis\".) Eosinophilic esophagitis has been associated with variety peptic esophagitis. absence endoscopic reflux esophagitis\".) It note that the accuracy of endoscopy for the diagnosis of GERD is subject to observer variability. (See \"Wireless though not necessarily histologically normal (see 'Histology' above). Una o m\u00e1s rupturas de la mucosa confinadas a los pliegues mucosos, cada uno < 5 mm. Por lo menos una ruptura de la mucosa > 5 mm, confinada a los pliegues mucosos pero sin continuidad en los bordes de dos de los pliegues. Por lo menos una ruptura de la mucosa entre los l\u00edmites de dos pliegues de la mucoosa, pero sin ser circuferencial. Ruptura circunferencial de findings \u2014 barium swallow examination is because sensitivity in patients with mild GERD. peptic stricture. A number a granular or nodular appearance of the mucosa of the distal third of the esophagus with numerous ill-defined, 1 to tiny collections the sometimes by a radiolucent of edematous appearance of a smooth, tapered area of concentric narrowing in the distal esophagus, 1 to 4 cm in length and 0.2 to 2.0 cm in diameter is virtually pathognomonic of appearance with puckering of GERD and normal upper endoscopy, especially if there is any associated dysphagia, even though esophageal manometry is of minimal atypical) who do not have evidence for mucosal damage on endoscopy, particularly if a trial of twice daily PPI has failed [27]. It can also be used to monitor the catheter or a wireless, capsule-shaped device that is affixed to the distal esophageal mucosa [29,30]. In each case, the pH sensor is coupled with compact, portable data recorders, and computerized data analysis. The catheter type pH electrode positioned 5 cm above defined upper limit of the lower esophageal sphincter. In the case of the wireless device, the pH capsule is attached 6 cm proximal to the endoscopically squamocolumnar junction. for a wireless device may the study for detecting studies should after withholding PPI therapy for seven days. However, in the case of the wireless device, studies can be conducted for two to four days, varying dietary and/or circumstances between consider the percentage time with the is of dubious significance since it can be provoked in 25 to 71 percent of symptomatic patients severity esophagitis. 10 to a standard dose Failure of the PPI treatment to resolve GERD-related symptoms has become the gastroenterologists. approach to patients with refractory GERD will be discussed here. A review of the medical management of GERD is presented separately. DEFINITIONS \u2014 Most patients with GERD who do respond to a PPI either response rate to PPI once daily at four weeks is 37 percent [5,6]. In contrast, in patients with erosive esophagitis, which for 30 pooled symptomatic 56 is controversial. Because refractory GERD is a patient-driven phenomenon, PPI failure in seek exclude true sufferers [7]. Most that only patients with GERD who exhibit partial or lack of response to PPI twice be considered as that lack of satisfactory symptomatic response PPI once a day [8]. However, patients commonly take their PPI incorrectly, which part be because they have not received adequate instructions. One study found that only 46 percent of patients prescribed a PPI for GERD were taking it properly Of those not taking it at bedtime and 4 percent as needed. Although there is no evidence that proper dosing can improve symptoms in patients who are not taking a PPI 30 minutes before breakfast, most authorities emphasize the need to ensure proper have demonstrated that poor compliance with PPIs is common in patients with GERD. By the end of one and six months of PPI therapy, only about 55 and 30 percent of the GERD patients, respectively, still consume their PPI once daily as initially instructed [10]. In a large, population-based study, the main influencing compliance were the presence or absence of symptoms, the severity of symptoms, and a personal preference about when to take treatment [11]. The results emphasize that GERD is a symptom-driven disease in which patients adhere to treatment instructions as long as they experience symptoms. Other general factors that affect compliance such as knowledge about the the should be in all GERD patients who report lack of response to PPI treatment, particularly prior to ordering any evaluative test. Unfortunately, to consume treatment on a daily basis. It is the role of the treating physician respond PPI twice daily demonstrated that up [13,14]. Thus, functional heartburn is the most common for failure of PPI treatment. The underlying mechanisms responsible for symptoms in functional III (burning retrosternal discomfort or pain, absence of evidence of GERD of symptoms, absence of histopathology-based esophageal motility disorders, months and six patient population [15-18]. heterogeneous analogous to the visceral hyperalgesia no evidence that weakly acidic reflux is more commonly measure the volume of the refluxate and thus cannot define the relationship between the volume and the acidity. Thus, it is impossible to determine individual thresholds been documented in patients with persistent heartburn despite a PPI once or twice daily [13,14,20-22]. As an example, in one study, 31 and 4 percent of GERD subjects with refractory symptoms who underwent pH testing on PPI once daily or PPI twice daily, respectively, had an abnormal test [23]. hand, studies demonstrated that reflux characteristics in PPI failure those in PPI success patients [24]. These studies the of the are pivotal for responsible for GERD symptoms [29]. On the other hand, experimental data support a role for persistent bile acids in to symptomatic reflux. included patients persistent heartburn and regurgitation refractory to PPI baclofen 20 centers with interest in gastrointestinal motility Residual acid reflux \u2014 Residual acid reflux has been documented in patients with persistent heartburn despite a PPI once or twice daily [13,14,20-22]. As an example, in one study, 31 and 4 percent of GERD subjects with refractory symptoms who underwent pH testing on PPI once daily or PPI twice daily, respectively, had an abnormal test [23]. hand, studies demonstrated that reflux characteristics in PPI failure those in PPI success patients [24]. These studies the of the are pivotal for responsible for GERD symptoms [29]. On the other hand, experimental data support a role for persistent bile acids in to symptomatic reflux. included patients persistent heartburn and regurgitation refractory to PPI baclofen 20 centers with interest in gastrointestinal motility Nocturnal acid to percent Nocturnal acid breakthrough (NAB) was initially proposed as a major cause of for 31 healthy controls [35]. Abnormal esophageal exposure significantly higher in patients with GERD and the severity of esophagitis (33 percent in patients with GERD and 50 percent in patients with GERD plus Barrett's esophagus versus 8 percent in controls). However, early NAB did one report, 71 percent of patients with GERD who did not respond to treatment with PPI twice daily experienced NAB, but only 36 percent had correlation between symptoms and NAB events [37]. In and nocturnal heartburn Thus, a significant for NAB in precipitating failure of PPI in metabolism Proton inhibitors may have a decreased effect on gastric acidity. On the other hand, absent in 3 percent of Caucasian and comparison of of acid-related disorders\".) Reduced bioavailability of varies and influenced the suppression of example, the bioavailability of omeprazole is approximately 30 to 40 percent at doses of 20 to 40 mg. In contrast, the bioavailability of lansoprazole is much higher at approximately 80 percent for doses ranging from 15 to 60 mg. Despite these differences, the two drugs have equivalent efficacy for achieving acid suppression. This was illustrated in a controlled crossover study in which meal-stimulated acid secretion was decreased by 48 and 82 percent with 15 and 30 mg lansoprazole, respectively, and by 39 and 83 percent with 20 and 40 mg of omeprazole, respectively [41]. The general pharmacokinetic a rare condition that may be caused by mutations in the proton pump gene, a relationship that has only been described in a 1995 abstract [7,43]. It is unlikely that this condition has any However, patients with severe esophagitis (eg, Los Angeles C D esophagitis) may take longer to heal. Helicobacter pylori status \u2014 PPIs produce a modest increase stomach to the corpus or fundus during PPI treatment. These areas of the stomach contain parietal cells, which are responsible for acid production. However, the prevalence of H. pylori infection has been rapidly in the United States and other developed countries, resulting in a very low background prevalence that cannot explain the large percentage symptoms with acid reflux events display a high level of anxiety and hysteria as compared with patients who demonstrate patients who did not respond to PPI therapy are more likely to have psychosocial comorbidity than those who were successfully treated \u2014 symptomatic is with be common among patients with refractory GERD. In one study of 65 patients with refractory GERD, sensitization to foods was present in 18 patients (28 percent) based upon the results of skin testing [58]. Eosinophils were found in the esophageal mucosa of patients who were food sensitized more often than in patients who were not (38 versus 7 percent), but only one patient was diagnosed food allergy: An overview\".) In one study, GERD had bowel severe achieve the same degree of symptom improvement during PPI treatment with disease of reflux events, or both as with cessation of smoking and avoidance of late meals: Head of bed elevation, which can be achieved either by putting 6- to 8-inch blocks under the legs at the head of the bed or a Styrofoam wedge under the mattress. Head of bed elevation is important for individuals with nocturnal or laryngeal ensures noncompliance. It is more practical to suggest avoidance of a core group of reflux-inducing foods (fatty foods, chocolate, peppermint, and excessive alcohol, which may reduce lower esophageal sphincter pressure) and then to suggest that the patient avoid foods known As number of have acidic pH and can exacerbate symptoms. These include colas, red wine, and orange juice (pH 2.5 to 3.9). Refraining from assuming a supine position after meals and avoidance of meals two to three hours before bedtime, both which or use use and elimination of deleterious in part because these approaches been extensively evaluated in trials. A systematic review of the published literature concluded that there was only evidence supporting the effectiveness of weight loss and head of bed elevation [9]. Abdominal breathing exercises have been suggested as a way to improve GERD with the rationale of strengthening the anti-reflux the a with 19 patients with nonerosive GERD [10]. After four weeks, patients no significant differences in scores between the abdominal breathing group and the controls. At the end of four weeks, the control patients crossed over to abdominal breathing exercises. After nine months, those still performing the exercises (n = 11) had significant improvement in life Because the study was small and failed to show a difference between the patients assigned to breathing patients, larger are required a GERD, symptom severity and previous can the selection of an initial acid suppressive regimen (table 1 and algorithm 1). The most common of peptic esophagitis or symptomatic H2 of for intragastric pH above 4 during the periods day that reflux is likely to occur [12]. The greater the degree of pathologic esophageal acid exposure, the greater the degree of acid suppression required. These therapies do not prevent reflux, but they acidity the \"Pathophysiology of reflux esophagitis\".) proton pump are compared the relative efficacy of these drugs is complicated by fact esophagitis exists rate is very healing esophagitis. However, do not exhibit a dose-response curve in the treatment of esophagitis. The H2 antagonist have for patients who continue to have heartburn after six weeks of treatment with a standard dose of an H2 antagonist [17]. to to placebo. addition, proton occurred at a rate of percent per week with a proton pump inhibitor compared to 6.4 percent among patients with GERD, proton pump inhibitor (PPI) treatment was superior to placebo or an H2 receptor antagonist. However, proton pump inhibitor therapeutic gain in patients compared with placebo in those who reported the symptom at baseline (0 to 35 percent). This was similar to the therapeutic gain seen for proton pump inhibitor treatment over that do not sometimes referred to as \"functional heartburn\". The first two groups, but not the third group of patients, may respond to antisecretory compared the various proton pump inhibitors to one another. While some differences have been reported, the magnitude of differences has been and and therefore impact the position of the gastric acid pocket, which serves as a reservoir for acid reflux [24]. However, it is unclear if treatment with to a reduction in GERD symptoms. In addition, their use is limited by side effects [11]. Consequently, there is currently no role of prokinetics as monotherapy or adjunctive therapy for the studies are higher however, has not been used as a because of its adverse side effect doses In trial, to moderate intensity that were comparable to the placebo group (45 versus 37 percent) [31]. The role of lesogaberan partially responding to PYLORI INFECTION \u2014 A of suggested in a number of studies. However, the link between GERD and H. pylori is complex and incompletely defined. The main linkage is in the effect that H. pylori has on gastric acid secretion. of H. is GERD in patients patients with who have a good clinical response to acid suppression with the exception of those with severe esophagitis on upper endoscopy (Los Angeles they are likely to have recurrent symptoms with discontinuation of acid suppression and are The for maintenance is by the manufacturer's prescribing information) or a lower dose (usually one-half of standard dose) were more effective than H2RAs promoting healing esophagitis at eight weeks. PPIs at a standard were more effective than a lower dose in preventing relapse of a standard were included 677 patients with mild to or ranitidine mg twice daily) [39]. which they were treated for two to four weeks with the drug that initially caused remission. At the end of one year, approximately 50 percent of patients in all three treatment groups had not "}